StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Anika Therapeutics's EV/EBITDA was 296.6× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 5.5× to 483.9×, with a median of 16.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026296.6×+223.5
2025Apr 30, 202573.0×+67.5
2024Dec 31, 20245.5×−198.9
2023Oct 31, 2023204.4×+154.7
2022Jul 29, 202249.8×+33.7
2020Oct 30, 202016.1×+3.6
2019Dec 31, 201912.6×+0.5
2018Dec 31, 201812.1×+0.0
2017Dec 29, 201712.1×+1.9
2016Dec 30, 201610.2×+0.8
2015Dec 31, 20159.4×+1.5
2014Dec 31, 20147.9×−6.2
2013Dec 31, 201314.1×+9.0
2012Dec 31, 20125.0×−2.5
2011Dec 30, 20117.6×−0.1
2010Dec 31, 20107.7×–

More Anika Therapeutics figures

See a number that looks wrong?